Division of Cardiology, Department of Internal Medicine, Cardiovascular Imaging Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Thoracic and Cardiovascular Surgery, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Echocardiography. 2022 Mar;39(3):447-456. doi: 10.1111/echo.15315. Epub 2022 Feb 14.
Recurrence of any atrial arrhythmia after surgical ablation is known as a negative predictor of cardiovascular events and total mortality. However, there have been no focused studies for atrial fibrillation (AF) recurrence prediction in patients with significant tricuspid regurgitation (TR), and the risk-benefit estimation of surgical ablation in tricuspid valve (TV) surgery is not fully established.
We screened 385 patients who underwent a TV operation between 2001 and 2017. After excluding patients who did not undergo a maze operation, 158 patients were enrolled. Enrolled patients were divided by recurrence of AF. We analyzed the difference between the AF recurrence group and no AF recurrence group, and AF recurrence factors in terms of clinical risk factors and echocardiographic risk factors. The hazard ratio (HR) and 95% confidence intervals (CIs) were presented using a Cox proportional hazard model.
Among 158 patients, AF recurred in 65 patients within 10 years. For AF prediction, age was most the important clinical factor and right atrium (RA) diameter was the most important echocardiographic parameters. In patients with a larger RA diameter over 49.2 mm, the prevalence of AF recurrence was higher (HR 4.322, 95% CI [2.185-8.549], log rank p value < .001). In clinical outcome, there was no significant difference between the AF recurrence group and the no recurrence group in terms of death, TR recurrence, heart failure, and stroke. However, the risk of permanent pacemaker (PPM) insertion was higher in the AF recurrence group (HR 10.240, 95% CI [1.257-83.480], log rank p value .007) compared to the no recurrence group.
Age and RA enlargement are key predictors of AF recurrence after TV operation with the CM procedure in patients with significant TR.
任何心房心律失常的术后复发均被认为是心血管事件和全因死亡率的负面预测因子。然而,目前尚无关于重度三尖瓣反流(TR)患者心房颤动(AF)复发预测的重点研究,且三尖瓣(TV)手术中手术消融的风险效益评估尚未完全确立。
我们筛选了 2001 年至 2017 年期间接受 TV 手术的 385 例患者。排除未行迷宫手术的患者后,共纳入 158 例患者。根据 AF 复发情况将入组患者进行分组。我们分析了 AF 复发组与无 AF 复发组之间的差异,并根据临床危险因素和超声心动图危险因素分析了 AF 复发的相关因素。采用 Cox 比例风险模型计算危险比(HR)及其 95%置信区间(CI)。
在 158 例患者中,10 年内有 65 例患者出现 AF 复发。对于 AF 预测,年龄是最重要的临床因素,右心房(RA)直径是最重要的超声心动图参数。在 RA 直径超过 49.2mm 的患者中,AF 复发的发生率更高(HR 4.322,95%CI [2.185-8.549],对数秩检验 p 值<.001)。在临床结局方面,AF 复发组与无复发组在死亡、TR 复发、心力衰竭和卒中方面无显著差异。然而,与无复发组相比,AF 复发组永久性起搏器(PPM)植入的风险更高(HR 10.240,95%CI [1.257-83.480],对数秩检验 p 值<.007)。
在重度 TR 患者中,CM 术式行 TV 手术后,年龄和 RA 增大是 AF 复发的关键预测因子。